SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-307202
Filing Date
2022-12-16
Accepted
2022-12-16 14:58:02
Documents
12
Period of Report
2022-12-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A d431066d8ka.htm   iXBRL 8-K/A 33260
  Complete submission text file 0001193125-22-307202.txt   162415

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221214.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221214_lab.xml EX-101.LAB 18703
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221214_pre.xml EX-101.PRE 11691
6 EXTRACTED XBRL INSTANCE DOCUMENT d431066d8ka_htm.xml XML 4286
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37695 | Film No.: 221467679
SIC: 2834 Pharmaceutical Preparations